SOGAZ-Med, insurance, results of the year

Affiliate material

The insurance company has summed up the interim results of its activities in 2018.

Today the company has more than 660 structural divisions on the territory of 40 constituent entities of Russia.

Number of insured persons in the company SOGAZ-Med is more than 19,4 million people (every 8th citizen living in the Russian Federation is insured by SOGAZ-Med). For 9 months of 2018, over a million people turned to the company to obtain or replace an OMI policy. Also, more than 2,1 million insured persons applied to the company for help on various issues.

During the reporting period of 2018, the company fully implemented its main priority tasks, including informing insured citizens about their rights and obligations in the CHI system. Branches of the company held more than 8000 public and social events, including visits of insurance representatives to enterprises, educational institutions, participation in patient schools and holding informational meetings in medical organizations.

In addition, for 9 months of 2018 the company SOGAZ-Med sent its insured 11,2 million messages with information about the possibility of undergoing medical examination, preventive medical examinations, as well as information on general issues of compulsory medical insurance. Including by means of SMS, viber and e-mail, 9,5 million informational messages were sent.

Employees of the company made more than 400 thousand phone calls in order to inform the insured, and more than 1,3 million were addressed to the citizens insured in the company. Thus, the indicator for informing for the same period in 2017 was exceeded by 25%.

For 20 years of work in the compulsory health insurance market, the company SOGAZ-Med became one of the leaders in terms of the number of innovative solutions in working with the population in the field of compulsory medical insurance. Active and efficient work to improve customer focus and improve service offers for insured persons is the basis of the long-term development strategy of SOGAZ-Med.

Leave a Reply